An Essential ProviderA Quiet Innovator

We were the first in the world to develop ‘hot sensation plasters’ and ‘analgesic and anti-inflammatory plasters’.

Rather than looking to expand the scale of our company, Teikoku Seiyaku instead aims to be what we like to call a “quiet innovator”, in the sense that we use technology that is unique to us. In the context of being a “quiet innovator”, Teikoku Seiyaku is a pioneer in the field of anti-inflammatory and analgesic plasters, succeeding in developing the first hot sensation plaster containing anti-inflammatory and analgesic medication that is absorbed through the skin. Since the company’s foundation we have continued in this vein and the tradition continues with Lidoderm® as the first prescription plaster approved for the treatment of post-herpetic neuralgia (PHN) in the United States.

  • Hot sensation plaster
    Hot sensation plaster *
    (Approved in Japan on September 28, 1977)
  • Indomethacin medicated plaster
    Indomethacin medicated plaster *
    (Approved in Japan on March 29, 1988)
  • Felbinac medicated plaster
    Felbinac medicated plaster *
    (Approved in Japan on July 2, 1993)
  • Lidocaine medicated plaster
    Lidocaine medicated plaster **
    (Approved in the U.S. on March 19, 1999)

* Original packaging * * Not sold in Japan